AEAlejandro Enriquez-Marulanda

Alejandro Enriquez-Marulanda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alejandro Enriquez-Marulanda has a total of 346 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Increased prevalence and size of incidental unruptured intracranial aneurysms in male smokers: A case-control study

    by Thomas B. Fodor, Tzak Lau, Mira Salih, Michael Young, Evelyn Turcotte, Vita Olson, Alejandro Enriquez-Marulanda, Samuel D. Pettersson, Jean Filo, Felipe Ramirez-Velandia, et al.


  • Open Access

    Clinical Predictors of Inpatient Mortality and Poor Postoperative Course After aSAH Microsurgical Clipping: A 10-Year Experience from a Peruvian Tertiary Care Center

    by Fernando Terry, Alejandro Enríquez-Marulanda, Nathaly Chinchihualpa-Paredes, Meiling Carbajal-Galarza, Claudia L Vidal-Cuellar, Guiliana Mas-Ubillus, Bruno Diaz-Llanes, Carlos Quispe-Vicuña, Niels Pacheco-Barrios, Rommel Arbulu-Zuazo, et al.

    Background/Objectives: Aneurysmal subarachnoid hemorrhage (aSAH) is a medical emergency with a high mortality rate requiring urgent treatment. This study aimed to identify clinical predictors of inpatient mortality and poor postoperative course after aSAH surgical clipping. Methods: We performed a retrospective review of medical records for 210 patients with aSAH treated via surgical clipping at our institution between 2010 and 2019. Baseline demographic data and clinical characteristics related to aSAH were collected. To identify factors associated with inpatient mortality and a poor postoperative course after aSAH microsurgical clipping, we conducted a univariate and bivariate analysis, as well as a multivariate analysis via the Poisson regression model. Results: The overall cumulative mortality over the 10-year study period was 11.43%. A severe WFNS scale score (aRR: 2.86; 95% CI: 1.28–6.39; p = 0.011) and having 1 (aRR: 5.76; 95% CI: 2.02–16.39, p = 0.001) or ≥2 (aRR: 18.86; 95% CI: 5.16–68.90, p < 0.001) postoperative neurosurgical complications were associated with an increased risk of inpatient mortality. A moderate (aRR: 3.71; 95% CI: 1.45–9.50; p = 0.006) or severe (aRR: 4.18; 95% CI: 1.12–15.60; p = 0.034) Glasgow scale score on admission, and presenting 1 (aRR: 2.31; 95% CI: 1.27–4.19; p = 0.006) or ≥2 postoperative clinical complications (aRR: 3.34; 95% CI: 1.83–6.10; p < 0.001) were associated with an increased risk of a poor postoperative course. Conclusions: While promising and widely supported by the published literature, these findings require further validation in a larger prospective and multi-centered study to adequately propose health policies on neurointensive care for the Peruvian population. Ultimately, developing socioeconomic setting-focused intervention algorithms and clinical practice guidelines could enhance the survival and postoperative course of patients presenting with aSAH.


  • Open Access

    Temporal Dynamics and Clinical Predictors of Brain Metastasis in Breast Cancer: A Two-Decade Cohort Analysis Toward Tailored CNS Screening

    by Fernando Terry, Eduardo Orrego-Gonzalez, Alejandro Enríquez-Marulanda, Niels Pacheco-Barrios, Martin Merenzon, Ricardo J. Komotar, Rafael A. Vega

    Background/Objectives: Breast cancer is the most common malignancy in women and the second leading cause of cancer-related deaths globally. It is also the second most frequent source of brain metastases (BMs), contributing to 5–20% of cases. Despite this, routine brain imaging for screening is not recommended and is only conducted when clinical symptoms or physical findings suggest metastasis. This study aims to identify clinical predictors associated with overall survival (OS) and the timing of BM development in breast cancer patients. Methods: We performed a retrospective review of medical records for 113 patients diagnosed with BMs secondary to breast cancer at our institution between 2000 and 2020. Baseline demographic data and clinical characteristics related to BMs were collected. To identify factors associated with OS and time to BM development after breast cancer diagnosis, we conducted univariate analysis using Kaplan–Meier curves, bivariate analysis with the log-rank test, and multivariate analysis via the Cox Proportional Hazard model. Results: An early diagnosis of BMs was identified as a significant predictor of prolonged OS (aHR = 0.22; 95% CI: 0.049–0.98, p = 0.05). Post-menopausal status at breast cancer diagnosis (aHR = 1.69; 95% CI: 1.13–2.53, p = 0.01), Asian ethnicity (aHR = 2.30; 95% CI: 1.03–5.16, p = 0.04), and the ER+/HER2+ subtype (aHR = 2.06; 95% CI: 1.14–3.71, p = 0.02) were significantly associated with a shorter time to BM diagnosis. A subgroup analysis of patients with ER+ breast tumors revealed that Hispanic or Arabic ethnicity (aHR = 3.63; 95% CI: 1.34–9.81, p = 0.01) and stage IV diagnosis (aHR = 2.09; 95% CI: 1.16–3.76, p = 0.01) were significantly associated with shorter intervals to BM diagnosis. Conclusions: Breast cancer remains a significant global health burden for women, yet clear guidelines for routine BMs screening are still lacking. Early detection of BMs has been shown to notably improve long-term survival outcomes. Additionally, post-menopausal status, Hispanic or Arabic ethnicity, and the HER2+ tumor subtype are associated with shorter time to BM development, highlighting these factors as potential indicators for central nervous system screening.

  • Open Access

    Stroke-Related Outcomes in Moyamoya Disease Compared with Moyamoya Syndromes: A Propensity-Matched Analysis

    by Aryan Wadhwa, Kimberly Han, Felipe Ramirez-Velandia, Omar Alwakaa, Coleman Riordan, Evan McNeil, Justin H. Granstein, Philipp Taussky, Alejandro Enriquez-Marulanda, Christopher S. Ogilvy


  • Open Access

    Socioeconomic Disparities in the Clinical Outcomes of Pediatric Traumatic Brain Injury: A Nationwide Analysis of the Past Decade

    by Aryan Wadhwa, Shashvat Purohit, Felipe Ramirez-Velandia, Alejandro Enriquez-Marulanda, Christopher S. Ogilvy


  • Open Access

    Foundations of Robotic Spine Surgery: Emerging Technologies and Future Directions

    by Fernando Terry, Alejandro Enriquez-Marulanda, Punit Pandya, Forough Yazdanian, Efstathios Papavassiliou, Ziev B. Moses

    Robotic technology is increasingly employed in minimally invasive spine surgery (MISS) to mitigate morbidity, operative duration, radiation exposure, and complications. The first FDA-approved (2004) robotic platform was the SpineAssist by Mazor Robotics, followed by the Mazor Renaissance (2011), and the Mazor X Stealth System (2016). These sequential Mazor generations featured enhancements in human interface, hardware, software, range of motion and system capacity. Additional robotic spine surgery systems are the ROSA robot by Zimmer Biomet, the ExcelsiusGPS by Globus Medical and REMI by Alphatec Spine. Some modern stations like the TiRobot have been approved by their country’s governmental regulatory agencies. As spine surgery increasingly transitions to outpatient settings, there is a growing preference for smaller robotic platforms. Lastly, robot-guided endoscopic spine surgery (ESS) represents a significant advancement in ultra-minimally invasive techniques, combining robotic precision with endoscopic methods to enhance surgical outcomes. While it offers benefits like reduced recovery time and improved visualization, challenges such as the steep learning curve and high costs exist, necessitating further long-term studies to evaluate its efficacy and viability. Based on this foundation, this chapter will delineate the historical progression of robotic spine surgery techniques, as well as explore the continuous emergence of novel modalities through rigorous methodological assessment.


  • Sequential Hemodynamic Analysis of Ruptured Posterior Communicating Artery Aneurysms Treated With Coil Embolization and Delayed Flow Diversion

    by Felipe Ramirez-Velandia, Vincenzo T. R. Loly, Alejandro Enriquez-Marulanda, Michael Young, Rafael T. Tatit, Arthur Cintra, Carlos E. Baccin, Max Shutran, Philipp Taussky, Christopher S. Ogilvy

    BACKGROUND AND OBJECTIVES: Computational fluid dynamics has advanced our knowledge of the pathogenesis of intracranial aneurysms and the dynamic changes observed after treatment. Herein, we analyze hemodynamic changes throughout the intervention stages for ruptured posterior communicating artery (PComA) aneurysms, treated with acute coiling and delayed flow diversion (FD). METHODS: We performed a retrospective analysis of ruptured PComA aneurysms treated with the acute coiling and delayed FD strategy between June 2013 to November 2022, using 3-dimensional reconstructions of digital subtraction angiographies. Hemodynamic simulations using ANSYS® calculated aneurysmal and adjacent arteries' wall shear stress (WSS), aneurysmal low shear areas (LSA), and mean velocities in the distal arteries. RESULTS: Six of the 22 patients were selected for computational fluid dynamics analysis, including 4 females and 2 males with a median age of 60 years. The average aneurysm volume was 984.12 mm3, with an average surface area of 386.11 mm2; LSA was 22.90%, and the average WSS was 3.39 Pa. The 2 largest aneurysms also had the highest LSA values. After coiling, there was a reduction in the aneurysmal volume (−78.42%) and the average surface area (−55.28%), and aneurysmal WSS increased to 6.10 Pa (+79.90%). WSS values for the middle cerebral artery (MCA) increased to 10.76 Pa, while anterior cerebral artery (ACA) increased to 7.51 Pa. Complete occlusion was achieved with delayed FD at a median follow-up of 19.7 months. After FD, average WSS increased to 14.94 Pa for the MCA (+70.64%) and to 10.82 Pa for the ACA (+30.10%). The mean MCA velocity increased to 43.04 cm/s (+36.85%), and 3 cases showed an increase in ACA velocities. CONCLUSION: LSA may have triggered rupture for the PComA aneurysms analyzed. After coiling, average WSS increased in the aneurysm wall and downstream vessels in the majority of cases analyzed. Delayed FD caused hemodynamic disturbances distal to deployment, reflected in the sequential increase in the WSS and velocities in both the ACA and MCA.


  • A Novel Scoring System Predicting Aneurysm Incomplete Occlusion After Flow Diversion: A 10-Year Experience

    by Felipe Ramirez-Velandia, Alejandro Enriquez-Marulanda, Jean Filo, Thomas B. Fodor, Daniel Sconzo, Emmanuel Mensah, Michael Young, Sandeep Muram, Justin H. Granstein, Max Shutran, et al.


  • Comparison of Postoperative Seizures Between Burr-Hole Evacuation and Craniotomy in Patients With Nonacute Subdural Hematomas: A Bi-Institutional Propensity Score–Matched Analysis

    by Felipe Ramirez-Velandia, Kasuni H. Ranawaka, Aryan Wadhwa, Mira Salih, Thomas B. Fodor, Tzak S. Lau, Niels Pacheco-Barrios, Alejandro Enriquez-Marulanda, Imad S. Khan, Rafael A. Vega, et al.

    BACKGROUND AND OBJECTIVES: Postoperative seizures are a common complication after surgical drainage of nonacute chronic subdural hematomas (SDHs). The literature increasingly supports the use of prophylactic antiepileptic drugs for craniotomy, a procedure that is often associated with larger collections and worse clinical status at admission. This study aimed to compare the incidence of postoperative seizures in patients treated with burr-hole drainage and those treated with craniotomy through propensity score matching (PSM). METHODS: A retrospective cohort analysis was conducted on patients with surgical drainage of nonacute SDHs (burr-holes and craniotomies) between January 2017 to December 2021 at 2 academic institutions in the United States. PSM was performed by controlling for age, subdural thickness, subacute component, and preoperative Glasgow Coma Scale. Seizure rates and accompanying abnormalities on electroencephalographic tracing were evaluated postmatching. RESULTS: A total of 467 patients with 510 nonacute SDHs underwent 474 procedures, with 242 burr-hole evacuations (51.0%) and 232 craniotomies (49.0%). PSM resulted in 62 matched pairs. After matching, univariate analysis revealed that burr-hole evacuations exhibited lower rates of seizures (1.6% vs 11.3%; P = .03) and abnormal electroencephalographic findings (0.0% vs 4.8%; P = .03) compared with craniotomies. No significant differences were observed in postoperative Glasgow Coma Scale (P = .77) and length of hospital stay (P = .61). CONCLUSION: Burr-hole evacuation demonstrated significantly lower seizure rates than craniotomy using a propensity score-matched analysis controlling for significant variables.


  • Open Access

    Cost-Effectiveness of Platelet Function Testing in Dual Antiplatelet Therapy Decision-Making after Intracranial Aneurysm Treatment with Flow Diversion

    by Aryan Wadhwa, Felipe Ramirez-Velandia, Emmanuel Mensah, Mira Salih, Alejandro Enriquez-Marulanda, Michael Young, Philipp Taussky, Christopher S. Ogilvy

    Introduction Dual antiplatelet therapy (DAPT) use is the standard of practice after flow diversion (FD) for intracranial aneurysms (IAs). Yet, no consensus exists in the literature regarding the optimal regimen. Certain institutions utilize various platelet function testing (PFT) to asses patient responsiveness to DAPT. Clopidogrel is the most commonly prescribed drug during DAPT, yet up to 52% of patients can be non-responders justifying PFT. Additionally, prices vary significantly among antiplatelet drugs, often further complicated by insurance restrictions. We aimed to determine the most cost-effective strategy for deciding DAPT regimens for patients after ICA treatment. Methods A decision tree with Monte Carlo simulations was performed to simulate patients undergoing various three-month postoperative DAPT regimens. Patients were either universally administered aspirin alongside Clopidogrel, Ticagrelor, or Prasugrel without PFT, or administered one of the former thienopyridine medications based on platelet reactivity unit (PRU) results after Clopidogrel. Input data for the model were extracted from the current literature, and the willingness-to-pay threshold (WTP) was defined as $100,000 per QALY as per standard practice in the US. The baseline comparison was with universal Clopidogrel DAPT without any PFT. Probabilistic and deterministic sensitivity analyses were performed to evaluate the robustness of the model. Results PFT-Prasugrel was the most cost-effective regimen compared to universal Clopidogrel, with a base-case incremental cost-effectiveness ratio (ICER) of $-35,255 (cost $2336.67, effectiveness 0.85). PFT-Ticagrelor (ICER $-4,671; cost $2,995.06, effectiveness 0.84), universal Prasugrel (ICER $5,553; cost $3,097.30, effectiveness 0.84), and universal Ticagrelor (ICER $75,969; cost $3,801.36, effectiveness 0.84) were all more cost-effective than treating patients with universal Clopidogrel (cost $3,041.77, effectiveness 0.83). These conclusions remain robust in probabilistic and deterministic sensitivity analyses. Conclusion The most cost-effective strategy for DAPT after FD for intracranial aneurysms is administering PFT-Prasugrel alongside aspirin. The cost of PFT is strongly justified and recommended when deciding patient-specific DAPT regimens.